Literature DB >> 15365228

Fungal infection but not type of bacterial infection is associated with a high mortality in primary and secondary infected pancreatic necrosis.

S Connor1, N Alexakis, T Neal, M Raraty, P Ghaneh, J Evans, M Hughes, P Rowlands, C J Garvey, R Sutton, J P Neoptolemos.   

Abstract

INTRODUCTION: Knowledge of microbiology in the prognosis of patients with necrotizing pancreatitis is incomplete. AIM: This study compared outcomes based on primary and secondary infection after surgery for pancreatic necrosis.
METHOD: From a limited prospective database of pancreatic necrosectomy, a retrospective case note review was performed (October 1996 to April 2003).
RESULTS: 55 of 73 patients had infected pancreatic necrosis at the first necrosectomy. 25 of 47 patients had resistant bacteria to prophylactic antibiotics (n = 21) or did not receive prophylactic antibiotics (n = 4), but this was not associated with a higher mortality (9 of 25) compared to those with sensitive organisms (4 of 22). Patients with fungal infection (n = 6) had a higher initial median (95% CI) APACHE II score compared to those without (11 (9-13) verus 8.5 (7-10), p = 0.027). Five of six patients with fungal infection died compared to 13 of 47 who did not (p = 0.014). With the inclusion of secondary infections 21 (32%) of 66 patients had fungal infection with 10 (48%) deaths compared to 11 (24%) of 45 patients without fungal infection (p = 0.047).
CONCLUSION: Whether associated with primary or secondary infected pancreatic necrosis, fungal but not bacterial infection was associated with a high mortality. Copyright 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2004        PMID: 15365228     DOI: 10.1159/000080884

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  8 in total

1.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  Analysis of the delayed approach to the management of infected pancreatic necrosis.

Authors:  Nilesh Doctor; Sujith Philip; Vidhyachandra Gandhi; Maharra Hussain; Savio G Barreto
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

Review 3.  Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis.

Authors:  Eduardo Villatoro; Mubashir Mulla; Mike Larvin
Journal:  Cochrane Database Syst Rev       Date:  2010-05-12

Review 4.  Management of infected pancreatic necrosis.

Authors:  Mike Larvin
Journal:  Curr Gastroenterol Rep       Date:  2008-04

5.  JPN Guidelines for the management of acute pancreatitis: medical management of acute pancreatitis.

Authors:  Kazunori Takeda; Tadahiro Takada; Yoshifumi Kawarada; Koichi Hirata; Toshihiko Mayumi; Masahiro Yoshida; Miho Sekimoto; Masahiko Hirota; Yasutoshi Kimura; Shuji Isaji; Masaru Koizumi; Makoto Otsuki; Seiki Matsuno
Journal:  J Hepatobiliary Pancreat Surg       Date:  2006

6.  Prognostic factors in patients undergoing surgery for severe necrotizing pancreatitis.

Authors:  R Mofidi; A C Lee; K K Madhavan; O J Garden; R W Parks
Journal:  World J Surg       Date:  2007-10       Impact factor: 3.282

7.  Prediction of invasive candidal infection in critically ill patients with severe acute pancreatitis.

Authors:  Alison M Hall; Lee A L Poole; Bryan Renton; Alexa Wozniak; Michael Fisher; Timothy Neal; Christopher M Halloran; Trevor Cox; Peter A Hampshire
Journal:  Crit Care       Date:  2013-03-18       Impact factor: 9.097

Review 8.  Severe acute pancreatitis: surgical indications and treatment.

Authors:  Max Heckler; Thilo Hackert; Kai Hu; Cristopher M Halloran; Markus W Büchler; John P Neoptolemos
Journal:  Langenbecks Arch Surg       Date:  2020-09-10       Impact factor: 3.445

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.